The Asian Oncology Society 1st Virtual International Conference

 

The Asian Oncology Society 1st Virtual International Conference
Z

Whole Course Management of Chemo-Induced Thrombocytopenia: How Do We Use Novel rhTPO as a SoC and Is It Better Than IL-11?

By The Asian Oncology Society 1st Virtual International Conference FEATURING Zhang Lingyun
By The Asian Oncology Society 1st Virtual International Conference FEATURING Zhang Lingyun
0 views
February 25, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Hematologic Oncology
15:18
The Asian Oncology Society 1st Virtual International Conference

Whole Course Management of Chemo-Induced Thrombocytopenia: How Do We…

Feat. Z. Lingyun
17:53
The Asian Oncology Society 1st Virtual International Conference

Imatinib for CML: Can We Achieve CCyR in All Stages? Can We Prolong …

Feat. Z. Aziz